Local Vape Retailer Faces Legal Action for Non-compliant Products and Counterfeit Cigarettes

Aug.02.2023
Local vape retailer, J&M Patterson Ltd, faces legal action for selling non-compliant nicotine vape products and counterfeit cigarettes.

Title: Local Vape Retailer Faces Legal Action for Non-compliant Products and Counterfeit Cigarettes

 

In a recent development, Muhammed Shuaab, director of J&M Patterson Ltd, a local nicotine vape retailer located at 33-35 High Street, Alness, has been subjected to legal requirements and restrictions by Tain Sheriff Court. The court order was issued by the High Council Trading Standards following intelligence that Shuaab was selling nicotine vapor (NVP or vape) products that did not comply with product safety and labeling requirements.

 

After a visit and warning from Trading Standards Officers, it was discovered that Shuaab had over 1000 NVPs in his possession that violated the product safety regulations. Consequently, these non-compliant products will now be confiscated and destroyed.

 

The Tobacco and Related Products Regulations 2016 state that the sale or possession of NVPs that do not comply with these rules is considered an offense. Offenders can be sentenced up to 12 months in prison or face a fine of up to £5,000, or both.

 

Particular concern arises from the potential health risks associated with unsafe NVPs lacking proper instructions, warnings, and information, especially for vulnerable individuals. The High Council's Trading Standards also suspects that retailers may be distributing single-use vapes with high nicotine concentrations.

 

Aside from product compliance, the court order imposes specific requirements on the retailer. Mr. Shuaab, as a registered business, is obligated to enforce a strict age verification policy to prevent the sale of NVPs to individuals under 18. Failure to comply with this policy is considered a criminal offense. Furthermore, Mr. Shuaab has been legally mandated to seek written authorization from persons under 18 before selling nicotine vapor products to them.

 

In addition to the non-compliant NVPs, a sleeve of "Richmond Blue" cigarettes, amounting to 200 cigarettes, was found in Shuaab's possession. These cigarettes, suspected to be counterfeit, were seized and handed over to the trademark holder for examination. Counterfeit cigarettes often contain harmful ingredients and lack legal liability for their safety.

 

The unauthorized sale of non-compliant NVPs and possession of counterfeit cigarettes are offenses under the Consumer Protection from Unfair Trading Regulations 2008. Shuaab's actions indicate a breach of the law, as he either falsely declared or intentionally created a misleading impression about his products.

 

Lastly, Shuaab is required to inform the Highland Council of any changes to his business name, personal name, or address for the next five years.

 

This order serves as a warning to all retailers to ensure compliance with product safety regulations and to refrain from engaging in the sale of counterfeit goods. The High Council Trading Standards will continue to monitor and take legal action against those who endanger public health and violate consumer protection laws.

 

Summary: Tain Sheriff Court has issued a court order against Muhammed Shuaab, a local nicotine vape retailer, for selling non-compliant NVPs and possessing counterfeit cigarettes. The order mandates compliance with product safety regulations, age verification policies, and the notification of changes to business details. Failure to adhere to these requirements can lead to imprisonment or fines. The High Council Trading Standards highlights the health risks associated with unsafe NVPs and the potential harm caused by counterfeit cigarettes.


Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

U.S. Expands Illicit Vape Enforcement as ATF Brings PACT Act Powers Into Trade Fraud Task Force
U.S. Expands Illicit Vape Enforcement as ATF Brings PACT Act Powers Into Trade Fraud Task Force
The U.S. Bureau of Alcohol, Tobacco, Firearms and Explosives said on September 23 that it has joined the interagency Trade Fraud Task Force to strengthen enforcement against illegal, misdeclared and smuggled vape and tobacco products. ATF will bring its authority under the Prevent All Cigarette Trafficking Act into the task force, including registration, reporting, shipping and record-inspection requirements covering interstate sales of electronic nicotine delivery systems. ATF said the move will strengthen its ability to trace illicit products from U.S. points of entry through domestic trafficking and distribution networks.
News
Sep.28 by 2Firsts Perspectives
South Korea's Tobacco Plan Excludes 6-Methyl Nicotine as Customs Tightens Import Controls and Analog Liquid Imports Fall 83%
South Korea's Tobacco Plan Excludes 6-Methyl Nicotine as Customs Tightens Import Controls and Analog Liquid Imports Fall 83%
South Korea's government unveiled its first Tobacco Harm Management Basic Plan for 2027–2031 on October 29, 2026, proposing broader testing of vaping and heated tobacco products while excluding nicotine analogs such as 6-methyl nicotine. Synthetic nicotine came under tobacco regulation on April 24, and a June investigation found 6-methyl nicotine in 12 liquid inhalation products marketed as nicotine-free. Customs data released in September showed that imports of nicotine analog solutions fell 83.3%, from 12 metric tons in January–April to 2 metric tons in May–August. By September 20, imports had reached approximately 15 metric tons for the year, with 99.99% originating from China. Customs authorities have tightened pre-clearance testing and supply-chain documentation requirements, while the MFDS expects to complete its assessment of nicotine analog hazards by the end of 2026.
Regulations
Nov.04
Australia's Illicit Tobacco Market May Have Turned After Five Years of Growth, With Estimates Showing Up to 25% Decline Amid Tax-Cut Debate
Australia's Illicit Tobacco Market May Have Turned After Five Years of Growth, With Estimates Showing Up to 25% Decline Amid Tax-Cut Debate
New Australian government estimates released on November 15, 2026, suggest that the country's illicit tobacco market may have contracted for the first time following five years of growth. Estimated market volume fell from a previous peak of 5,972 tonnes to a range of 4,453–5,893 tonnes. The government attributed the change to stronger border enforcement and coordinated domestic operations. Australian Border Force seized more than 2,300 tonnes of illicit tobacco and 13.2 million illicit vaping products in 2025–26, followed by approximately 730 tonnes of illicit tobacco in the first quarter of 2026–27. Separate experimental estimates from the Australian Bureau of Statistics indicate that illicit sources accounted for approximately 80% of nicotine consumption in 2025.
Regulations
Nov.16
2Firsts Hosts China Market Forum at InterTabac as Global Industry Attention to China’s Tobacco Sector Deepens
2Firsts Hosts China Market Forum at InterTabac as Global Industry Attention to China’s Tobacco Sector Deepens
On September 16, 2Firsts hosted a China-focused industry forum during InterTabac in Dortmund, bringing together more than 30 participants from North America, Europe, India, South Korea and other markets. The session covered traditional tobacco, next-generation products, exports, technology, regulation and supply chains, while examining how China’s tobacco sector operates, where its transformation may be heading, and why its growing role matters increasingly to companies across the global tobacco and nicotine industry.
Sep.21
Special Report | Can Nicotine Be Replaced? 6-MN Is Already on the Market While Key Human Evidence Is Still Missing
Special Report | Can Nicotine Be Replaced? 6-MN Is Already on the Market While Key Human Evidence Is Still Missing
Nicotine analogues such as 6-methylnicotine are already appearing in e-cigarettes and oral pouches, even as key human evidence remains limited. A new Nixodine-S study adds nonclinical data showing differences from nicotine in cytotoxicity and receptor activity, while independent studies point to a more complex toxicological picture. With supply-chain activity growing and FDA seeking clearer authority over nicotine analogues, the industry now faces a larger question: what evidence is needed before these substances can credibly replace nicotine?
SCIENCE
Sep.23
Australia Adds 6-Methylnicotine to Schedule 9 Prohibited Substances, Effective October 1
Australia Adds 6-Methylnicotine to Schedule 9 Prohibited Substances, Effective October 1
Australia's Therapeutic Goods Administration published a final decision on September 25 to classify 6-methylnicotine as a Schedule 9 prohibited substance under the Poisons Standard, effective October 1, 2026. TGA said the chemical has been reported in e-cigarette liquids sold in Australia and marketed as nicotine-free or nicotine alternatives, while evidence also indicates its use in preparations such as oral pouches. The government originally proposed a Schedule 7 classification but ultimately adopted the stricter Schedule 9 designation, citing acute toxicity, dependence risk, use in unapproved consumer products and misleading marketing.
News
Sep.29 by 2Firsts Perspectives